How do metabolic diseases in India and China reflect broader public health challenges in the Asia-Pacific region?
India and China have the highest burden of metabolic diseases in the Asia-Pacific. I want to understand how this situation is connected to larger public health issues, such as lifestyle, healthcare access, and government policies.